A citation-based method for searching scientific literature

K L Burns, K Ueki, S L Jhung, J Koh, D N Louis. J Neuropathol Exp Neurol 1998
Times Cited: 102

List of co-cited articles
749 articles co-cited >1

Times Cited
  Times     Co-cited

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
K Ueki, Y Ono, J W Henson, J T Efird, A von Deimling, D N Louis. Cancer Res 1996

Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.
W Biernat, Y Tohma, Y Yonekawa, P Kleihues, H Ohgaki. Acta Neuropathol 1997

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.
J Pomerantz, N Schreiber-Agus, N J Liégeois, A Silverman, L Alland, L Chin, J Potes, K Chen, I Orlow, H W Lee,[...]. Cell 1998

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
E E Schmidt, K Ichimura, G Reifenberger, V P Collins. Cancer Res 1994

A cell cycle regulator potentially involved in genesis of many tumor types.
A Kamb, N A Gruis, J Weaver-Feldhaus, Q Liu, K Harshman, S V Tavtigian, E Stockert, R S Day, B E Johnson, M H Skolnick. Science 1994

Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
Y Ono, T Tamiya, T Ichikawa, K Kunishio, K Matsumoto, T Furuta, T Ohmoto, K Ueki, D N Louis. J Neuropathol Exp Neurol 1996

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
J G Herman, J R Graff, S Myöhänen, B D Nelkin, S B Baylin. Proc Natl Acad Sci U S A 1996

Cancer cell cycles.
C J Sherr. Science 1996

PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Y Tohma, C Gratas, W Biernat, A Peraud, M Fukuda, Y Yonekawa, P Kleihues, H Ohgaki. J Neuropathol Exp Neurol 1998

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
G Reifenberger, L Liu, K Ichimura, E E Schmidt, V P Collins. Cancer Res 1993

The retinoblastoma gene is involved in malignant progression of astrocytomas.
J W Henson, B L Schnitker, K M Correa, A von Deimling, F Fassbender, H J Xu, W F Benedict, D W Yandell, D N Louis. Ann Neurol 1994

Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.
Y Hayashi, K Ueki, A Waha, O D Wiestler, D N Louis, A von Deimling. Brain Pathol 1997

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.
A Merlo, J G Herman, L Mao, D J Lee, E Gabrielson, P C Burger, S B Baylin, D Sidransky. Nat Med 1995

Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
K Watanabe, K Sato, W Biernat, O Tachibana, K von Ammon, N Ogata, Y Yonekawa, P Kleihues, H Ohgaki. Clin Cancer Res 1997

Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.
E W Newcomb, H Cohen, S R Lee, S K Bhalla, J Bloom, R L Hayes, D C Miller. Brain Pathol 1998

Deletion of p16 and p15 genes in brain tumors.
J Jen, J W Harper, S H Bigner, D D Bigner, N Papadopoulos, S Markowitz, J K Willson, K W Kinzler, B Vogelstein. Cancer Res 1994

Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.
J F Costello, M S Berger, H S Huang, W K Cavenee. Cancer Res 1996

MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
T Moulton, G Samara, W Y Chung, L Yuan, R Desai, M Sisti, J Bruce, B Tycko. Am J Pathol 1995

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
P A Steck, M A Pershouse, S A Jasser, W K Yung, H Lin, A H Ligon, L A Langford, M L Baumgard, T Hattier, T Davis,[...]. Nat Genet 1997

Subsets of glioblastoma multiforme defined by molecular genetic analysis.
A von Deimling, K von Ammon, D Schoenfeld, O D Wiestler, B R Seizinger, D N Louis. Brain Pathol 1993

Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.
W Biernat, P Kleihues, Y Yonekawa, H Ohgaki. J Neuropathol Exp Neurol 1997

MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p.
K Ueki, M P Rubio, V Ramesh, K M Correa, J L Rutter, A von Deimling, A J Buckler, J F Gusella, D N Louis. Hum Mol Genet 1994

Somatic mutations of PTEN in glioblastoma multiforme.
S I Wang, J Puc, J Li, J N Bruce, P Cairns, D Sidransky, R Parsons. Cancer Res 1997

PTEN mutations in gliomas and glioneuronal tumors.
E M Duerr, B Rollbrocker, Y Hayashi, N Peters, B Meyer-Puttlitz, D N Louis, J Schramm, O D Wiestler, R Parsons, C Eng,[...]. Oncogene 1998

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.
T Nobori, K Miura, D J Wu, A Lois, K Takabayashi, D A Carson. Nature 1994

Role of the INK4a locus in tumor suppression and cell mortality.
M Serrano, H Lee, L Chin, C Cordon-Cardo, D Beach, R A DePinho. Cell 1996

CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.
J He, J R Allen, V P Collins, M J Allalunis-Turner, R Godbout, R S Day, C D James. Cancer Res 1994

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994

Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
J Reifenberger, G U Ring, U Gies, L Cobbers, J Oberstrass, H X An, D Niederacher, W Wechsler, G Reifenberger. J Neuropathol Exp Neurol 1996

Loss of P16INK4 expression is frequent in high grade gliomas.
R Nishikawa, F B Furnari, H Lin, W Arap, M S Berger, W K Cavenee, H J Su Huang. Cancer Res 1995

Structural alterations of the epidermal growth factor receptor gene in human gliomas.
A J Wong, J M Ruppert, S H Bigner, C H Grzeschik, P A Humphrey, D S Bigner, B Vogelstein. Proc Natl Acad Sci U S A 1992

The p53 gene and protein in human brain tumors.
D N Louis. J Neuropathol Exp Neurol 1994

Genetic alterations associated with the evolution and progression of astrocytic brain tumours.
H Ohgaki, B Schäuble, A zur Hausen, K von Ammon, P Kleihues. Virchows Arch 1995

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
J Li, C Yen, D Liaw, K Podsypanina, S Bose, S I Wang, J Puc, C Miliaresis, L Rodgers, R McCombie,[...]. Science 1997

Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas.
J Fueyo, C Gomez-Manzano, J M Bruner, Y Saito, B Zhang, W Zhang, V A Levin, W K Yung, A P Kyritsis. Oncogene 1996

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
F J Stott, S Bates, M C James, B B McConnell, M Starborg, S Brookes, I Palmero, K Ryan, E Hara, K H Vousden,[...]. EMBO J 1998

A novel p16INK4A transcript.
L Mao, A Merlo, G Bedi, G I Shapiro, C D Edwards, B J Rollins, D Sidransky. Cancer Res 1995

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
J G Cairncross, K Ueki, M C Zlatescu, D K Lisle, D M Finkelstein, R R Hammond, J S Silver, P C Stark, D R Macdonald, Y Ino,[...]. J Natl Cancer Inst 1998

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.